Przejdź do zawartości
Merck

11976826001

Roche

MIA ELISA

sufficient for ≤96 tests, Roche, kit of 1 (9 components), suitable for ELISA

Synonim(y):

ELISA

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych


About This Item

Kod UNSPSC:
41116158

zastosowanie

sufficient for ≤96 tests

Poziom jakości

opakowanie

kit of 1 (9 components)

producent / nazwa handlowa

Roche

metody

ELISA: suitable

temp. przechowywania

2-8°C

Opis ogólny

One-step immunoreaction—photometric enzyme immunoassay for the quantitative in vitro determination of human Melanoma Inhibitory Activity (MIA) in streptavidin-coated microplates.
Standards: Six standards, ranging from 0 to 50 ng/ml MIA protein, are provided with lot-specific data.

Specyficzność

The MIA ELISA detects natural and recombinant human melanoma inhibitory activity protein. No cross-reaction with other serum components has been found.

Immunogen

Detailed epitope structure is not known. The epitopes recognized by the antibodies are conformation epitopes, no linear structures. This is why the abs are not suitable for Western (denaturation destroys epitopes). The two antibodies recognize different epitopes (non-overlapping).

The antibodies recognize non-overlapping epitopes, which are conformational epitopes (no linear sequence is recognized but rather parts of 3D-conformation). Exact epitopes have not been determined.

Zastosowanie

For research use only. Not for use in diagnostic procedures.
The MIA ELISA is an ideal application in research studies determining the melanoma inhibitory activity protein in serum and plasma.
The MIA ELISA is specially developed for the quantitative in vitro determination of MIA protein in serum and plasma within streptavidin-coated microplates (MPs). It has a wide applictaion in MIA (melanoma inhibitory activity) ELISA assays.[1]

Opakowanie

1 kit containing 9 components.

Uwaga dotycząca przygotowania

Working solution: Beside the ready-to-use solutions supplied with this kit, you will need to prepare the following working solution:
  1. Anti-MIA-Biotin: Reconstitute the lyophilizate in 0.7 ml double-dist. water for 10 minutes at 15 to 25 °C and mix thoroughly. Do not vortex.
    Result: A clear, colorless solution.
  2. Anti-MIA-Peroxidase: Reconstitute the lyophilizate in 0.7 ml double-dist. water for 10 minutes at 15 to 25 °C, and mix thoroughly. Do not vortex.
    Result: A clear, slightly yellowish solution.
  3. MIA Standard: Reconstitute the lyophilizate in 0.5 ml double-dist. water for 10 minutes at
    15 to 25 °C, and mix thoroughly.Do not vortex.
    Result: A clear, colorless solution. Concentration indicated on the label.
  4. MIA Control Serum: Reconstitute the lyophilizate in 0.3 ml double-dist. water for 10 minutes at 15 to 25 °C, and mix thoroughly. Do not vortex.
    Result: A Slightly opalescent and yellowish solution. Concentration indicated on the label.
  5. Washing Buffer : Dissolve one tablet in 2 l of double-dist. water.
    Result: A clear, colorless solution.
  6. Immunoreagent: For 8 wells (1.8 ml): Add 50 μl reconstituted anti-MIA-Peroxidase (solution 2) to 1.7 ml Incubation Buffer, and mix well. Then add 50 μl of anti-MIA-biotin
    (solution 1), and mix thoroughly. Do not vortex.
    Result: A clear, colorless solution.
All lyophilizates should be clear solutions after reconstitution. Any particles in the reconstituted solution should be considered as evidence of deterioration. Precipitates or cloudiness in the reagent solutions should also be considered as indications of deterioration.
Roche recommends using only double distilled water for the reconstitution of lyophylizates.
Storage conditions (working solution): Anti-MIA-Biotin (vial 1):
6 months at -15 to -25 °C or ≤ -60 °C when aliquoted and shock-frozen
Anti-MIA-Peroxidase (vial 2):
6 months at -15 to -25 °C or ≤ -60 °C when aliquoted and shock-frozen
MIA-Standard (vial 3):
1 day at 2 to 8 °C or 6 months at -15 to -25 °C or ≤ -60 °C when aliquoted and shock-frozen
MIA-Control Serum (vial 4):
1 day at 2 to 8 °C or 6 months at -15 to -25 °C or ≤ -60 °C when aliquoted and shock-frozen
Washing Buffer (vial 6): 1month at 2 to 8 °C
Immunoreagent: 8 hours at 2 to 8 °C
Ta strona może zawierać tekst przetłumaczony maszynowo.

Tylko elementy zestawu

Numer produktu
Opis

  • Anti-MIA-biotin antibody, monoclonal from mouse, lyophilized (clone 2.F7.3B1)

  • Anti-MIA-peroxidase antibody, monoclonal from mouse, lyophilized (clone 1.A12.9A1)

  • MIA Standard, lyophilized

  • MIA Control Serum, MIA in human serum, lyophilized approximately 25 ng/ml

  • Incubation Buffer ready-to-use

  • Washing Buffer

  • ABTS Substrate Solution ready-to-use

  • Streptavidin-coated Microplate modules

  • Self-adhesive Plate Cover Foils

Zobacz wszystko (9)

Piktogramy

Exclamation mark

Hasło ostrzegawcze

Warning

Zwroty wskazujące rodzaj zagrożenia

Zwroty wskazujące środki ostrożności

Klasyfikacja zagrożeń

Aquatic Chronic 3 - Skin Sens. 1

Kod klasy składowania

12 - Non Combustible Liquids

Klasa zagrożenia wodnego (WGK)

WGK 3

Temperatura zapłonu (°F)

does not flash

Temperatura zapłonu (°C)

does not flash


Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

Nie widzisz odpowiedniej wersji?

Jeśli potrzebujesz konkretnej wersji, możesz wyszukać konkretny certyfikat według numeru partii lub serii.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Miyako Kurihara-Shimomura et al.
International journal of oncology, 56(5), 1093-1100 (2020-04-23)
Mast cells (MCs) are present in the tumor stroma, and MCs that express the mast cell‑specific proteases tryptase and chymase (MCTC) exhibit several tumor‑related functions. It was previously reported that melanoma inhibitory activity (MIA) gene family members, including MIA, MIA2
Harriet M Kluger et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 17(8), 2417-2425 (2011-04-14)
With the rising incidence of melanoma, more patients are undergoing surveillance for disease recurrence. Our purpose was to study levels of proteins that might be secreted in the blood of patients with metastatic melanoma that can be used for monitoring

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej